RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $718,113 | -16.9% | 85,388 | +24.1% | 0.00% | 0.0% |
| Q2 2023 | $864,455 | -27.6% | 68,826 | -5.1% | 0.00% | -50.0% |
| Q1 2023 | $1,193,943 | +5.0% | 72,492 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $1,137,606 | -26.1% | 76,145 | +10.6% | 0.00% | -20.0% |
| Q3 2022 | $1,540,000 | +74.8% | 68,833 | +30.8% | 0.01% | +150.0% |
| Q2 2022 | $881,000 | -68.4% | 52,605 | -43.5% | 0.00% | -66.7% |
| Q1 2022 | $2,786,000 | -2.6% | 93,100 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,859,000 | +19.8% | 93,100 | +23.0% | 0.01% | +20.0% |
| Q3 2021 | $2,387,000 | -13.8% | 75,700 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $2,770,000 | +29.9% | 75,700 | +22.7% | 0.01% | +20.0% |
| Q1 2021 | $2,133,000 | +13.0% | 61,700 | +35.9% | 0.01% | +25.0% |
| Q4 2020 | $1,887,000 | -13.1% | 45,400 | -11.0% | 0.00% | -20.0% |
| Q3 2020 | $2,172,000 | – | 51,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |